Teva Pharmaceutical Industries (TEVA) Capital Expenditures Growth (1y) (2010 - 2026)
Teva Pharmaceutical Industries (TEVA) Capital Expenditures Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | 8.33% |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | -19.86% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -1.95% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 73.63% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -0.19% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -37.60% |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | -42.11% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.11 Bn | 7.46 Bn | 397.90 Mn | -37.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.33% |
| Mar 31, 2026 | 32.28% |
| Dec 31, 2025 | 10.08% |
| Sep 30, 2025 | -8.11% |
| Jun 30, 2025 | -1.03% |
| Mar 31, 2025 | 2.42% |
| Dec 31, 2024 | 8.40% |
| Sep 30, 2024 | -0.67% |
| Jun 30, 2024 | -18.49% |
| Mar 31, 2024 | -10.79% |
| Dec 31, 2023 | -16.20% |
| Sep 30, 2023 | 22.13% |
| Jun 30, 2023 | -6.30% |
| Mar 31, 2023 | -11.46% |
| Dec 31, 2022 | -7.19% |
| Sep 30, 2022 | -16.44% |
| Jun 30, 2022 | 12.39% |
| Mar 31, 2022 | 4.67% |
| Dec 31, 2021 | -13.07% |
| Sep 30, 2021 | 2.10% |